STAND. COM. REP. NO. 1191

Honolulu, Hawaii

, 2019

RE: H.B. No. 665

H.D. 2

Honorable Scott K. Saiki

Speaker, House of Representatives

Thirtieth State Legislature

Regular Session of 2019

State of Hawaii

Sir:

Your Committees on Judiciary and Consumer Protection & Commerce, to which was referred H.B. No. 665, H.D. 1, entitled:

"A BILL FOR AN ACT RELATING TO THE ELECTRONIC PRESCRIPTION ACCOUNTABILITY SYSTEM,"

beg leave to report as follows:

The purpose of this measure is to exempt:

(1) Health care providers from the requirement to consult the electronic prescription accountability system when prescribing controlled substances to patients in an inpatient setting or in hospice care; and

(2) Patients who are in an inpatient setting and lack capacity from the required informed consent process for opioid therapy.

The Department of Health, Department of Public Safety, Hawaii Health Systems Corporation, The Queen's Health Systems, and Healthcare Association of Hawaii testified in support of this measure. Kaiser Permanente Hawaii and the Hawaii Association for Justice provided comments.

Your Committees have amended this measure by:

(1) Expanding the exemption relating to the electronic prescription accountability system to include prescriptions for patients being treated for post-operative pain with an initial prescription that is limited to a three-day supply; and

(2) Making technical, nonsubstantive amendments for clarity, consistency, and style.

Should this measure progress through the legislative process, your Committees request that future Committees consider the concerns raised by the Hawaii Association for Justice regarding the informed consent exemption for opioid therapy patients.

As affirmed by the records of votes of the members of your Committees on Judiciary and Consumer Protection & Commerce that are attached to this report, your Committees are in accord with the intent and purpose of H.B. No. 665, H.D. 1, as amended herein, and recommend that it pass Third Reading in the form attached hereto as H.B. No. 665, H.D. 2.

Respectfully submitted on behalf of the members of the Committees on Judiciary and Consumer Protection & Commerce,

____________________________ ROY M. TAKUMI, Chair

____________________________ CHRIS LEE, Chair